Lyophilized from 0.22µm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Expression System:
HEK293
Purity:
> 95% as determined by Bis-Tris PAGE,> 95% as determined by HPLC
Form:
Lyophilized
Sequence:
Ser27-Asn756
Target:
VEGF R1/FLT-1
Human VEGF R1 on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Immobilized Human PGF, hFc Tag at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Human VEGF R1, His Tag with the EC50 of 53.4ng/ml determined by ELISA.
Immobilized Human VEGF R1, His Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Biotinylated Human VEGF121, His Tag with the EC50 of 40.3ng/ml determined by ELISA (QC Test).
Biotinylated Human VEGF165, His Tag captured on CM5 Chip via streptavidin can bind Human VEGF R1, His Tag with an affinity constant of 1.36 pM as determined in SPR assay (Biacore T200).
Immobilized Human VEGF R1, His Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Human VEGF165, Llama IgG2b Fc Tag with the EC50 of 69.9ng/ml determined by ELISA.
The purity of Human VEGF R1 is greater than 95% as determined by SEC-HPLC.
* VAT and and shipping costs not included. Errors and price changes excepted
